Advances and Future Directions in Percutaneous Coronary Intervention (PCI)

Dear Colleagues,

We are excited to serve as the Guest Editors for a Special Issue of the Journal of Clinical Medicine dedicated to current progress and future directions in interventional cardiology to be published in May 2025. This Special Issue, titled “Advances and Future Directions in Percutaneous Coronary Interventions (PCI)”, will focus on current advances in coronary artery disease and intervention.

In recent years, there has been significant progress in the field of interventional cardiology from novel devices (including thin-strut second-generation drug-eluting stents, sirolimus-coated balloons, new-generation bioresorbable scaffolds, and bioadaptors) to appealing antithrombotic strategies (e.g., P2Y12 inhibitor monotherapy in place of aspirin, very short dual antiplatelet therapy, dual antiplatelet therapy P2Y12 inhibitor de-escalation, and aspirin-free antithrombotic therapy after percutaneous coronary intervention). In addition, a substantial amount of new evidence on intravascular imaging techniques (i.e., intravascular ultrasound and optical coherence tomography) for guiding and optimizing percutaneous coronary interventions has strengthened recommendations and raised new questions. Similarly, multiple recent trials on percutaneous coronary intervention in patients with acute myocardial infarction and multivessel disease have enhanced our undestanding on the prognostic value of myocardial revascularization completeness, timing, and guidance. Finally, emerging angiography-based techniques to assess coronary physiology (quantitative flow ratio, non-invasive index of microvascular resistance, etc.) open new diagnostic opportunities. The goal of this Special Issue is to update the practicing interventional cardiologist and provide a comprehensive collection of review articles.

To this end, we would like to invite state-of-the-art reviews focusing on advances in percutaneous coronary interventions, including the evolution of interventional techniques, new devices for percutaneous coronary intervention, and medical therapy (i.e., antithrombotic therapy in coronary artery disease).

The deadline for the submission of these articles to the journal is 31 May 2025. We look forward to your submissions.

Dr. Daniele Giacoppo
Dr. Antonio Greco
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.